Molecular genetics of mitochondrial disorders

Developmental Disabilities Research Reviews

Volumn 16, Issue 2, 2010, Pages 154-162

  Wong, Lee Jun C ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Mitochondrial disorder; mtDNA deletion; mtDNA depletion; mtDNA mutation

Indexed keywords

MITOCHONDRIAL DNA;

BIOGENESIS; COMPARATIVE GENOMIC HYBRIDIZATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA MICROARRAY; DNA REPLICATION; DNA TRANSCRIPTION; GENE DELETION; GENE TARGETING; HUMAN; MITOCHONDRIAL DNA DEPLETION SYNDROME; MITOCHONDRION; MOLECULAR GENETICS; POINT MUTATION; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS;

EID: 77956255221     PISSN: 19405510     EISSN: 10982779     Source Type: Journal    
DOI: 10.1002/ddrr.104     Document Type: Review

References (96)

1. Antonicka H, Mattman A, Carlson CG, et al. 2003. Mutations in COX15 produce a defect in the mitochondrial heme biosynthetic pathway, causing early-onset fatal hypertrophic cardiomyopathy. Am J Hum Genet 72:101-114.
2. Bai RK, Wong LJ. 2004. Detection and quantification of heteroplasmic mutant mitochondrial DNA by real-time amplification refractory mutation system quantitative PCR analysis: a single-step approach. Clin Chem 50:996-1001.
3. Bianchi MS, Bianchi NO, Bailliet G. 1995. Mitochondrial DNA mutations in normal and tumor tissues from breast cancer patients. Cytogenet Cell Genet 71:99-103.
4. Bourdon A, Minai L, Serre V, et al. 2007. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat Genet 39:776-780.
5. Brautbar A, Wang J, Abdenur JE, et al. 2008. The mitochondrial 13513G>A mutation is associated with Leigh disease phenotypes independent of complex I deficiency in muscle. Mol Genet Metab 94:485-490.
6. Bykhovskaya Y, Casas K, Mengesha E, et al. 2004. Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet 74:1303-1308. (Pubitemid 38669331)
7. Bykhovskaya Y, Mengesha E, Fischel-Ghodsian N. 2007. Pleiotropic effects and compensation mechanisms determine tissue specificity in mitochondrial myopathy and sideroblastic anemia (MLASA). Mol Genet Metab 91:148-156.
8. Calvo S, Jain M, Xie X, et al. 2006. Systematic identification of human mitochondrial disease genes through integrative genomics. Nat Genet 38:576-582.
9. Carrozzo R, Dionisi-Vici C, Steuerwald U, et al. 2007. SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness. Brain 130:862-874.
10. Chinault AC, Shaw CA, Brundage EK, et al. 2009. Application of dual-genome oligonucleotide array-based comparative genomic hybridization to the molecular diagnosis of mitochondrial DNA deletion and depletion syndromes. Genet Med 11:518-526.
11. Corral-Debrinski M, Horton T, Lott MT, et al. 1992. Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nat Genet 2:324-329.
12. de Lonlay P, Valnot I, Barrientos A, et al. 2001. A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure. Nat Genet 29:57-60.
13. Dieteren CE, Willems PH, Vogel RO, et al. 2008. Subunits of mitochondrial complex I exist as part of matrix- and membrane-associated subcomplexes in living cells. J Biol Chem 283:34753-34761.
14. DiMauro S. 2004. The many faces of mitochondrial diseases. Mitochondrion 4:799-807.
15. Dimmock D, Tang LY, Schmitt ES, et al. 2010. Quantitative evaluation of the mitochondrial DNA depletion syndrome. Clin Chem 56: 1119-1127.
16. Dimmock DP, Zhang Q, Dionisi-Vici C, et al. 2008. Clinical and molecular features of mitochondrial DNA depletion due to mutations in deoxyguanosine kinase. Hum Mutat 29:330-331.
17. Edvardson S, Shaag A, Kolesnikova O, et al. 2007. Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia. Am J Hum Genet 81:857-862. (Pubitemid 47596554)
18. El-Hattab AW, Li FY, Schmitt E, et al. 2010. MPV17-associated hepatocerebral mitochondrial DNA depletion syndrome: new patients and novel mutations. Mol Genet Metab 99:300-308.
19. Elliott HR, Samuels DC, Eden JA, et al. 2008. Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 83:254-260.
20. Elpeleg O, Miller C, Hershkovitz E, et al. 2005. Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. Am J Hum Genet 76:1081-1086.
21. Enns GM, Bai RK, Beck AE, et al. 2006. Molecular-clinical correlations in a family with variable tissue mitochondrial DNA T8993G mutant load. Mol Genet Metab 88:364-371.
22. Fernandez-Vizarra E, Berardinelli A, Valente L, et al. 2007. Nonsense mutation in pseudouridylate synthase 1 (PUS1) in two brothers affected by myopathy, lactic acidosis and sideroblastic anaemia (MLASA). J Med Genet 44:173-180.
23. Galbiati S, Bordoni A, Papadimitriou D, et al. 2006. New mutations in TK2 gene associated with mitochondrial DNA depletion. Pediatr Neurol 34:177-185.
24. Geisler S, Holmstrom KM, Skujat D, et al. 2010. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol 12:119-131.
25. Gempel K, Topaloglu H, Talim B, et al. 2007. The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring- flavoprotein dehydrogenase (ETFDH) gene. Brain 130:2037-2044.
26. Gropman A, Chen TJ, Perng CL, et al. 2004. Variable clinical manifestation of homoplasmic G14459A mitochondrial DNA mutation. Am J Med Genet A 124A:377-382. (Pubitemid 38141379)
27. Haas RH, Parikh S, Falk MJ, et al. 2007.Mitochondrial disease: a practical approach for primary care physicians. Pediatrics 120:1326-1333.
28. Haas RH, Parikh S, Falk MJ, et al. 2008. The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab 94:16-37.
29. Hakonen AH, Isohanni P, Paetau A, et al. 2007. Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion. Brain 130:3032-3040.
30. Hoefs SJ, Dieteren CE, Distelmaier F, et al. 2008. NDUFA2 complex I mutation leads to Leigh disease. Am J Hum Genet 82:1306-1315.
31. Horton TM, Petros JA, Heddi A, et al. 1996. Novel mitochondrial DNA deletion found in a renal cell carcinoma. Genes Chromosomes Cancer 15:95-101. (Pubitemid 26048409)
32. Horvath R, Hudson G, Ferrari G, et al. 2006. Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene. Brain 129:1674-1684.
33. Houstek J, Kmoch S, Zeman J. 2009. TMEM70 protein - a novel ancillary factor of mammalian ATP synthase. Biochim Biophys Acta 1787:529-532.
34. Jessie BC, Sun CQ, Irons HR, et al. 2001. Accumulation of mitochondrial DNA deletions in the malignant prostate of patients of different ages. Exp Gerontol 37:169-174.
35. Kenmochi N, Yoshihama M, Higa S, et al. 2000. The human ribosomal protein L6 gene in a critical region for Noonan syndrome. J Hum Genet 45:290-293.
36. Koene S, Smeitink J. 2009. Mitochondrial medicine: entering the era of treatment. J Intern Med 265:193-209.
37. Lacbawan F, Tifft CJ, Luban NL, et al. 2000. Clinical heterogeneity in mitochondrial DNA deletion disorders: a diagnostic challenge of Pearson syndrome. Am J Med Genet 95:266-268.
38. Lagier-Tourenne C, Tazir M, Lopez LC, et al. 2008. ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency. Am J Hum Genet 82:661-672.
39. Lamantea E, Tiranti V, Bordoni A, et al. 2002. Mutations of mitochondrial DNA polymerase gammaA are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia. Ann Neurol 52:211-219.
40. Lee NC, Dimmock D, Hwu WL, et al. 2009. Simultaneous detection of mitochondrial DNA depletion and single-exon deletion in the deoxyguanosine gene using array-based comparative genomic hybridisation. Arch Dis Child 94:55-58.
41. Liang MH, Wong LJ. 1998. Yield of mtDNA mutation analysis in 2,000 patients. Am J Med Genet 77:395-400. (Pubitemid 28283685)
42. Lutz RE, Dimmock D, Schmitt ES, et al. 2009. De novo mutations in POLG presenting with acute liver failure or encephalopathy. J Pediatr Gastroenterol Nutr 49:126-129.
43. Mandel H, Szargel R, Labay V, et al. 2001. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet 29:337-341.
44. Mardis ER. 2009. New strategies and emerging technologies for massively parallel sequencing: applications in medical research. Genome Med 1:40.
45. Miller C, Saada A, Shaul N, et al. 2004. Defective mitochondrial translation caused by a ribosomal protein (MRPS16) mutation. Ann Neurol 56:734-738.
46. Milone M, Brunetti-Pierri N, Tang LY, et al. 2008. Sensory ataxic neuropathy with ophthalmoparesis caused by POLG mutations. Neuromuscul Disord 18:626-632.
47. Milone M, Younge BR, Wang J, et al. 2009. Mitochondrial disorder with OPA1 mutation lacking optic atrophy. Mitochondrion 9:279-281.
48. Mollet J, Delahodde A, Serre V, et al. 2008. CABC1 gene mutations cause ubiquinone deficiency with cerebellar ataxia and seizures. Am J Hum Genet 82:623-630.
49. Mollet J, Giurgea I, Schlemmer D, et al. 2007. Prenyldiphosphate synthase, subunit 1 (PDSS1) and OH-benzoate polyprenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders. J Clin Invest 117:765-772.
50. Naimi M, Bannwarth S, Procaccio V, et al. 2006. Molecular analysis of ANT1, TWINKLE and POLG in patients with multiple deletions or depletion of mitochondrial DNA by a dHPLC-based assay. Eur J Hum Genet 14:917-922.
51. Naviaux RK, Nguyen KV. 2004. POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion. Ann Neurol 55:706-712.
52. Nguyen KV, Ostergaard E, Ravn SH, et al. 2005. POLG mutations in Alpers syndrome. Neurology 65:1493-1495.
53. Nishino I, Spinazzola A, Hirano M. 1999. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283:689-692. (Pubitemid 129506238)
54. Ostergaard E, Christensen E, Kristensen E, et al. 2007a. Deficiency of the alpha subunit of succinate-coenzyme A ligase causes fatal infantile lactic acidosis with mitochondrial DNA depletion. Am J Hum Genet 81: 383-387.
55. Ostergaard E, Hansen FJ, Sorensen N, et al. 2007b. Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations. Brain 130:853-861.
56. Pagliarini DJ, Calvo SE, Chang B, et al. 2008. A mitochondrial protein compendium elucidates complex I disease biology. Cell 134:112-123.
57. Patton JR, Bykhovskaya Y, Mengesha E, et al. 2005. Mitochondrial myopathy and sidero-blastic anemia (MLASA): missense mutation in the pseudouridine synthase 1 (PUS1) gene is associated with the loss of tRNA pseudouridylation. J Biol Chem 280:19823-19828.
58. Quinzii C, Naini A, Salviati L, et al. 2006. A mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency. Am J Hum Genet 78:345-349. (Pubitemid 43157573)
59. Quinzii CM, Kattah AG, Naini A, et al. 2005. Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation. Neurology 64:539-541.
60. Saada A, Vogel RO, Hoefs SJ, et al. 2009. Mutations in NDUFAF3 (C3ORF60), encoding an NDUFAF4 (C6ORF66)-interacting complex I assembly protein, cause fatal neo-natal mitochondrial disease. Am J Hum Genet 84:718-727.
61. Saneto RP, Lee IC, Koenig MK, et al. 2010. POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders. Seizure 19:140-146.
62. Sarzi E, Goffart S, Serre V, et al. 2007. Twinkle helicase (PEO1) gene mutation causes mitochondrial DNA depletion. Ann Neurol 62:579-587.
63. Scheper GC, van der Klok T, van Andel RJ, et al. 2007. Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat Genet 39:534-539.
64. Shaibani A, Shchelochkov OA, Zhang S, et al. 2009. Mitochondrial neurogastrointestinal encephalopathy due to mutations in RRM2B. Arch Neurol 66:1028-1032.
65. Shanske S, Wong LJ. 2004. Molecular analysis for mitochondrial DNA disorders. Mitochondrion 4:403-415. (Pubitemid 39646794)
66. Shchelochkov OA, Li FY, Geraghty MT, et al. 2009. High-frequency detection of deletions and variable rearrangements at the ornithine trans-carbamylase (OTC) locus by oligonucleotide array CGH. Mol Genet Metab 96:97-105.
67. Smeitink J, van den Heuvel L, DiMauro S. 2001. The genetics and pathology of oxidative phosphorylation. Nat Rev Genet 2:342-352.
68. Smeitink JA, Elpeleg O, Antonicka H, et al. 2006. Distinct clinical phenotypes associated with a mutation in the mitochondrial translation elongation factor EFTs. Am J Hum Genet 79:869-877.
69. Soong NW, Hinton DR, Cortopassi G, et al. 1992. Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nat Genet 2:318-323.
70. Spelbrink JN, Li FY, Tiranti V, et al. 2001. Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet 28:223-231.
71. Spinazzola A, Invernizzi F, Carrara F, et al. 2009. Clinical and molecular features of mitochondrial DNA depletion syndromes. J Inherit Metab Dis 32:143-158.
72. Spinazzola A, Viscomi C, Fernandez-Vizarra E, et al. 2006. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet 38:570-575.
73. Spinazzola A, Zeviani M. 2005. Disorders of nuclear-mitochondrial intergenomic signaling. Gene 354:162-168.
74. Spinazzola A, Zeviani M. 2007. Disorders of nuclear-mitochondrial intergenomic communication. Biosci Rep 27:39-51.
75. Spinazzola A, Zeviani M. 2009. Disorders from perturbations of nuclear-mitochondrial intergenomic cross-talk. J Intern Med 265:174-192.
76. Tan DJ, Bai RK, Wong LJ. 2002. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res 62:972-976. (Pubitemid 34160271)
77. Tay SK, Shanske S, Kaplan P, et al. 2004. Association of mutations in SCO2, a cytochrome c oxidase assembly gene, with early fetal lethality. Arch Neurol 61:950-952.
78. Tiranti V, Hoertnagel K, Carrozzo R, et al. 1998. Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am J Hum Genet 63:1609-1621.
79. Valente L, Shigi N, Suzuki T, et al. 2009. The R336Q mutation in human mitochondrial EFTu prevents the formation of an active mt-EFTu.GTP.aa-tRNA ternary complex. Biochim Biophys Acta 1792:791-795.
80. Valnot I, Osmond S, Gigarel N, et al. 2000. Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy. Am J Hum Genet 67: 1104-1109.
81. Van Goethem G, Dermaut B, Lofgren A, et al. 2001. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat Genet 28:211-212.
82. Van Goethem G, Martin JJ, Dermaut B, et al. 2003. Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Neuromuscul Disord 13:133-142.
83. Van Hove JL, Cunningham V, Rice C, et al. 2009. Finding twinkle in the eyes of a 71-year-old lady: a case report and review of the genotypic and phenotypic spectrum of TWINKLE-related dominant disease. Am J Med Genet A 149A:861-867.
84. Vasta V, Ng SB, Turner EH, et al. 2009. Next generation sequence analysis for mitochondrial disorders. Genome Med 1:100.
85. Wallace DC. 1999. Mitochondrial diseases in man and mouse. Science 283:1482-1488.
86. Wallace DC, Lott MT, Brown MD, et al. 2001. Mitochondria and neuro-ophthalmologic diseases. In:Scriver CR, Beaudet AL, Sly WS, et al., editors.The metabolic and molecular bases of inherited disease, Vol II. New York: McGraw-Hill. p2425-2509.
87. Wallace DC, Shoffner JM, Trounce I, et al. 1995. Mitochondrial DNA mutations in human degenerative diseases and aging. Biochim Biophys Acta 1271:141-151.
88. Willems PH, Valsecchi F, Distelmaier F, et al. 2008. Mitochondrial Ca2+ homeostasis in human NADH:ubiquinone oxidoreductase deficiency. Cell Calcium 44:123-133.
89. Wong LJ. 2001. Recognition of mitochondrial DNA deletion syndrome with non-neuro-muscular multisystemic manifestation. Genet Med 3:399-404.
90. Wong LJ, Brunetti-Pierri N, Zhang Q, et al. 2007. Mutations in the MPV17 gene are responsible for rapidly progressive liver failure in infancy. Hepatology 46:1218-1227.
91. Wong LJ, Dimmock D, Geraghty MT, et al. 2008a. Utility of oligonucleotide array-based comparative genomic hybridization for detection of target gene deletions. Clin Chem 54:1141-1148.
92. Wong LJ, Naviaux RK, Brunetti-Pierri N, et al. 2008b. Molecular and clinical genetics of mitochondrial diseases due to POLG mutations. Hum Mutat 29:E150-E172.
93. Wong LJ, Scaglia F, Graham BH, et al. 2010. Current molecular diagnostic algorithm for mitochondrial disorders. Mol Genet Metab 100:111-117.
94. Wong LJ, Senadheera D. 1997. Direct detection of multiple point mutations in mitochondrial DNA. Clin Chem 43:1857-1861. (Pubitemid 27452273)
95. Zhang S, Li FY, Bass HN, et al. 2010. Application of oligonucleotide aCGH to the simultaneous detection of a deletion in the nuclear TK2 gene and mtDNA depletion. Mol Genet Metab 99:53-57.
96. Zhu Z, Yao J, Johns T, et al. 1998. SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat Genet 20:337-343.